Associated Papers
Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.
De Brakeleer S et al.
Mutation Research, 2007
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
Majdak EJ et al.
European Journal of Cancer (oxford, England : 1990), 2005
Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features.
Berns EM et al.
British Journal of Cancer, 2001
Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.
Claes K et al.
Disease Markers, 1999
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
Claes K et al.
Human Mutation, 1999
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.
Verhoog LC et al.
Lancet (london, England), 1998
Select a paper to view details